Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, David Isenberg, Maria Efthymiou et al.|The Lancet Haematology|2016Cited by 404
GAPSS: the Global Anti-Phospholipid Syndrome ScoreSavino Sciascia, María Laura Bertolaccini|Lara D. Veeken|2013Cited by 310